SystImmune Revenue and Competitors
Estimated Revenue & Valuation
- SystImmune's estimated annual revenue is currently $8.5M per year.
- SystImmune's estimated revenue per employee is $155,000
Employee Data
- SystImmune has 55 Employees.
- SystImmune grew their employee count by 28% last year.
SystImmune Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is SystImmune?
Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune system to attack the tumor. We are a group of highly experienced immuno-oncology scientists utilizing several technology platforms to develop world class advanced antibody-based drug therapies.
keywords:N/A
N/A
Total Funding
55
Number of Employees
$8.5M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Redmond
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.4M | 55 | 6% | N/A |
#2 | $16.2M | 55 | 12% | N/A |
#3 | $7.3M | 56 | 33% | N/A |
#4 | $7.3M | 56 | 22% | N/A |
#5 | $16.7M | 57 | 36% | N/A |